Unifarco

Unifarco S.p.A., founded in 1982 and headquartered in Santa Giustina (Belluno), reported revenues of 187 million euros in 2024, with EBITDA of 28 million euros and approximately 800 employees.

The Group develops, manufactures, and distributes a portfolio of dermocosmetic, nutraceutical, functional food, and make-up products, comprising:

• the community brand Farmacisti Preparatori, a European leader in the pharmacy channel
• proprietary specialist brands including Ceramol, Dolomia, MyCli, Biomalife, Genage, and Keylife

Unifarco operates an in-house R&D department, with a dedicated team and more than 20 registered patents, supporting continuous innovation.